Memorial Şişli Hospital
Umbilical cord stem cell therapy in Turkey typically costs from AUD $7,189 to AUD $13,228. Prices depend on the specific condition treated, the required cell dosage, and the clinic's laboratory technology. Patients save around 55% by travelling to Turkey from Australia, where this therapy costs AUD $22,861 on average. Most Turkish packages include specialist consultations, lab processing, and VIP airport transfers.
Bookimed Expert Insight: Quality often depends on laboratory standards rather than just hospital size. Liv Hospital Ulus features a GMP-standard Regenerative Medicine Centre, which means its cell processing meets strict international safety audits. Professor Erdal Karaöz, who founded Turkey’s first institutional stem cell R&D centre, leads cellular therapies here. Choosing clinics with such dedicated, hospital-grade laboratories ensures better cell viability for Australian patients seeking high-standard care.
| Turkey | Thailand | South Korea | |
| Umbilical cord stem cell therapy | from AUD $7,189 | from AUD $14,378 | from AUD $13,659 |
No hidden fees – just official clinic prices. Pay at the clinic for Umbilical cord stem cell therapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Umbilical cord stem cell therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Umbilical cord stem cell therapy journey.
Dr. Husrev Diktas is an Associate Professor of Infectious Diseases at Medipol Acibadem District Hospital. He specializes in vaccine immunology and molecular biology. Dr. Diktas served as an Associate Research Scientist at the Yale School of Medicine. He conducted research there to improve vaccines against tick-borne diseases like Lyme and Babesiosis.
Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.
Dr. Sevil Bilir is an associate professor and pediatrician at Medipol Acibadem District Hospital in Istanbul. She holds a PhD in pediatrics from Istanbul Haydarpaşa Numune Training and Research Hospital. Dr. Bilir has worked extensively in both public university hospitals and private medical centers. She treats children and teens for a variety of general and specialized health conditions.
Dr. Erdal Karaöz is a pioneer in regenerative medicine at Liv Hospital Ulus. He established the first private stem cell production center in Turkey under GMP standards. He previously conducted stem cell research at Harvard University in Boston. Dr. Karaöz founded the first institutional stem cell R&D center in Turkey at Kocaeli University.
Umbilical cord stem cell therapy in Turkey is generally safe at JCI-accredited clinics using Good Manufacturing Practice (GMP) laboratories. Common side effects include temporary fever, injection site redness, or fatigue. While rare, serious risks include blood clots, infection from contaminated cultures, or immune reactions to cell media.
Bookimed Expert Insight: High-quality Turkish centres use closed-system cell processing rather than manual handling. Prof. Erdal Karaöz at Liv Hospital managed ministry-approved clinical trials using these strict protocols. Patients should prioritise clinics with on-site GMP laboratories. This significantly reduces the risk of cell contamination during transport or cryobanking.
Patient Consensus: Patients in Turkey often report short-term anxiety or irritability similar to high-dose steroids. Most emphasise that verifying laboratory sterility and GMP compliance is vital. These factors are more important than hotel-style amenities or package inclusions.
Verifying clinic quality for stem cell therapy in Turkey involves confirming Joint Commission International (JCI) accreditation. You should also check for Good Manufacturing Practice (GMP) laboratory standards. Reliable centres like Liv Hospital Ulus and Memorial Şişli Hospital use closed-system processing. They also use Ministry-approved clinical trial protocols for cell viability and patient safety.
Bookimed Expert Insight: Data shows Turkey’s leading stem cell centres maintain internal GMP labs (LivMedCell). Choosing a clinic with on-site production ensures higher cell freshness and stricter sterility. Istanbul centres now serve patients from over 167 countries.
Patient Consensus: Patients in Turkey recommend requesting written cell dose and processing data. They suggest prioritising doctor-led clinics over marketing-focused centres. Success often depends on clear follow-up plans. Patients should also verify the exact cell source, like umbilical cord matrix, before arrival.
Turkish specialists use umbilical cord mesenchymal stem cells to treat chronic neurological, autoimmune, and musculoskeletal conditions. Common applications include cerebral palsy, multiple sclerosis, spinal cord injuries, and osteoarthritis. Accredited facilities like Liv Hospital Ulus use GMP-standard labs for precise cell isolation and sterile processing.
Bookimed Expert Insight: Success in Turkey often links to what happens after the injection. Specialists like Dr. Asena Paran or Dr. Erdal Karaöz emphasise neuroplasticity-focused rehabilitation after therapy. This structured post-treatment support helps patients translate biological cellular changes into functional improvements. These include better walking or reduced spasticity.
Patient Consensus: Patients in Turkey typically focus on symptom relief for multiple sclerosis. They also seek help for spinal cord injuries and chronic nerve pain. Most report incremental gains in bladder control and sensation rather than total cures.
Turkey is a leading centre for umbilical cord stem cell therapy. It has strong Good Manufacturing Practice (GMP) laboratories and JCI-accredited hospitals. Specialists use allogeneic mesenchymal stem cells from umbilical cord matrix. These treat complex neurological, orthopaedic, and autoimmune conditions.
Bookimed Expert Insight: Bookimed data shows Turkey provides fast access to regenerative medicine compared to Australia. While Australian patients often face long waits for trials, Turkish centres have virtually no waiting lists. Medipol Mega University Hospital serves 1,000,000+ patients annually. This high-volume environment allows clinicians to refine protocols across thousands of cases.
Patient Consensus: Patients value the combination of cost-effective care and professional medical-tourism support in Turkey. Many describe a friendly atmosphere. They find that integrated travel and interpretation services make navigating complex treatments much easier.
Umbilical cord stem cells in Turkey are collected from donors after healthy deliveries using sterile, non-invasive methods. Processing occurs in specialised Good Manufacturing Practice (GMP) laboratories. Technicians isolate and expand mesenchymal stem cells (MSCs) from the cord matrix before cryopreservation or clinical use.
Bookimed Expert Insight: Turkish facilities like Liv Hospital Ulus often have internal GMP-standard production centres on-site. This allows professors like Dr Erdal Karaöz to oversee the entire chain from isolation to infusion. These integrated hospital labs provide higher cell viability than clinics that outsource their manufacturing.
Patient Consensus: Patients value transparency regarding donor screening and laboratory standards in Turkey. Many recommend asking for written proof of cell viability and passage numbers. This confirms the treatment is fresh and potent.
An umbilical cord stem cell treatment trip to Turkey typically lasts 5 to 10 days. Simple cases may require only 3 nights. Complex neurological or orthopaedic conditions often involve a 14-day stay. This extended window allows for rehabilitation and physical therapy alongside the cell administration.
Bookimed Expert Insight: Turkish specialists often differentiate between the travel window and the therapeutic window. While the procedure finishes in days, clinics like Rumi Pulse focus on the 3 to 6 month window for results. Choosing a centre with established Good Manufacturing Practice labs helps ensure cells are processed locally. This often reduces the wait time for administration.
Patient Consensus: The trip is usually a short medical visit focused on the procedure with brief in-country monitoring. People suggest planning for gradual improvements over 12 months rather than expecting immediate results during the stay in Turkey.